Drug intelligence / Profile preview

Acupoint application

Development stage: Unknown
Lead developer: Guang'anmen Hospital
Modality: Small Molecules
Administration: Topical

Overview

Acupoint application (Guang'anmen Hospital) is a Traditional Chinese Medicine (TCM) therapeutic intervention developed by Guang'anmen Hospital of China Academy of Chinese Medical Sciences. It involves the topical application of a specific herbal formulation to acupuncture points to treat joint pain in patients with knee osteoarthritis, particularly those with cold-dampness obstruction syndrome. The treatment is designed to provide analgesic and anti-inflammatory effects through the transdermal absorption of herbal active ingredients at targeted sites. It has been evaluated in Phase 3 clinical trials as a non-invasive alternative or adjunct to conventional pain management.

Other names: TCM acupoint applicationAcupoint application of Traditional Chinese medicine

Beyond the preview

Go deeper on Acupoint application.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acupoint application.

Explore the full profile